» Articles » PMID: 35055534

Post-Exposure Prophylaxis and Methamphetamine Use Among Young Sexual Minority Men: The P18 Cohort Study

Overview
Publisher MDPI
Date 2022 Jan 21
PMID 35055534
Authors
Affiliations
Soon will be listed here.
Abstract

Methamphetamine use is associated with increased risk of HIV infection among young sexual minority men (SMM). Post-exposure prophylaxis (PEP) is an effective strategy for individuals who are exposed to HIV, but there is limited research about PEP use among young SMM and its relationship with methamphetamine use. This study analyzes the association between ever PEP use and recent methamphetamine use among young SMM in New York City, using cross-sectional data from the P18 Cohort Study ( = 429). Multivariable logistic regression models were used to assess the association between methamphetamine use and ever PEP use. Compared with those who had not used methamphetamine in the last 6 months, young SMM who did use methamphetamine were significantly more likely to have ever used PEP (AOR = 6.07, 95% CI: 2.10-16.86). Young SMM who had ever used PrEP had 16 times higher odds of ever using PEP (AOR = 16, 95% CI: 7.41-35.95). Those who completed bachelor's degrees were 61% less likely to have ever used PEP (AOR = 0.39, 95% CI: 0.17-0.88). These data suggest that methamphetamine use could increase the risk of HIV infection, highlighting the critical need to target interventions for young SMM who use methamphetamine and are more likely to engage in unprotected intercourse.

Citing Articles

The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.

John S, Sizemore K, Jimenez R, Jones S, Petroll A, Rendina H JMIR Public Health Surveill. 2022; 8(12):e31237.

PMID: 36306518 PMC: 9804091. DOI: 10.2196/31237.

References
1.
Koblin B, Usher D, Nandi V, Tieu H, Bravo E, Lucy D . Post-exposure Prophylaxis Awareness, Knowledge, Access and Use Among Three Populations in New York City, 2016-17. AIDS Behav. 2018; 22(8):2718-2732. DOI: 10.1007/s10461-018-2175-5. View

2.
Cardo D, Culver D, Ciesielski C, Srivastava P, Marcus R, Abiteboul D . A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997; 337(21):1485-90. DOI: 10.1056/NEJM199711203372101. View

3.
McMahan V, Moreno C, Al-Tayyib A, Menza T, Orellana E, Bhattarai A . Pre-exposure Prophylaxis Awareness and Use Among Cisgender Men Who Have Sex With Men and Use Methamphetamine in 3 Western US Cities. Sex Transm Dis. 2020; 47(4):217-223. PMC: 7071950. DOI: 10.1097/OLQ.0000000000001128. View

4.
Hong F, Mellors J . Impact of Antiretroviral Therapy on HIV-1 Persistence: The Case for Early Initiation. AIDS Rev. 2015; 17(2):71-82. View

5.
Semple S, Zians J, Grant I, Patterson T . Methamphetamine use, impulsivity, and sexual risk behavior among HIV-positive men who have sex with men. J Addict Dis. 2006; 25(4):105-14. DOI: 10.1300/J069v25n04_10. View